CNTX – context therapeutics inc. (US:NASDAQ)
Stock Stats
News
Are You Looking for a Top Momentum Pick? Why Context Therapeutics Inc. (CNTX) is a Great Choice [Yahoo! Finance]
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $4.50 price target on the stock.
Context Therapeutics Inc. (NASDAQ: CNTX) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $4.50 price target on the stock.
Context Therapeutics Inc. (CNTX) Upgraded to Buy: Here's Why [Yahoo! Finance]
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
Form 4 Context Therapeutics For: Jun 13 Filed by: Stacey Jennifer Evans
Form 4 Context Therapeutics For: Jun 13 Filed by: Kantoff Philip W.
Form 4 Context Therapeutics For: Jun 13 Filed by: West Linda
Form 4 Context Therapeutics For: Jun 13 Filed by: BERMAN RICHARD J
Form 8-K Context Therapeutics For: Jun 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.